Here, we carried out whole-exome sequencing (WES) analysis of breast cancers classified by ESR1 expression, and identified novel somatic mutations by exclusion of SNPs in the whole blood cells of patients with breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.